chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 38.0
Sex: M
Vaccine: ANTH
Symptoms: Product administered at inappropriate site, Pruritus, Pyrexia, Rhinitis
Clinical narrative: He reports notable erythema, warmth, edema, pruritus to his upper arm. He reports paresthesia?s and neuralgic pain to his left hand and fingers. He denies paresis or paralysis. He reports the vaccine site was very high on his shoulder, and had initial severe shoulder pain about an hour after receipt, which has resolved, and he reports normal ROM. He states he had flulike symptoms of fever, rhinitis, cough, malaise for 7 days starting prior to receipt, which his children had similar symptoms before his developed.  POC today: -Ibuprofen 800 mgs tid with food -Cetirazine 10 mgs daily, may repeat q12 severe pruritis -Topical lidex 0.05% AAA -Temporary medically reactive exemption. I would defer next dose until full 18 months have passed and recommend premedication with ibuprofen 800 mgs 1-4 hours prior to receipt. He reports he will be on duty and can contact or clinic to mange receipt at the time. -File VAERS report He also reports site placement of injection as ?too high?. He currently has normal ROM and denies significant pain. Paresthesia?s can be associated with Post immunization arthropathy, however we will assess further if they don?t clear with his local site reaction.
Age: 35.0
Sex: F
Vaccine: COVID19-2
Symptoms: Asthma, Blood culture negative, COVID-19, Condition aggravated, Cough
Clinical narrative: Patient is 35 years old with past medical history of plantar fasciitis presented to the hospital with a chief complaint of shortness of breath associated with sore throat that has been worsening over the last 2 days.  Patient has noticed multiple wheezing nonproductive cough over the last couple days as well.  Patient was found to have COVID in the ER.  When seen, patient continues to have shortness of breath.  Otherwise patient has no fever, chills, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, difficulty with urination,   Clinical Summary Patient's work of breathing secondary to covid infection and asthma exacerbation improved with antibiotics, dexamethasone, and remdesivir.  Patient did no
Age: 35.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dyspnoea, Hypophosphataemia, Laboratory test, Oropharyngeal pain, Pneumonia
Clinical narrative: Patient is 35 years old with past medical history of plantar fasciitis presented to the hospital with a chief complaint of shortness of breath associated with sore throat that has been worsening over the last 2 days.  Patient has noticed multiple wheezing nonproductive cough over the last couple days as well.  Patient was found to have COVID in the ER.  When seen, patient continues to have shortness of breath.  Otherwise patient has no fever, chills, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, difficulty with urination,   Clinical Summary Patient's work of breathing secondary to covid infection and asthma exacerbation improved with antibiotics, dexamethasone, and remdesivir.  Patient did no
Age: 35.0
Sex: F
Vaccine: COVID19-2
Symptoms: Procalcitonin normal, Superinfection, Wheezing
Clinical narrative: Patient is 35 years old with past medical history of plantar fasciitis presented to the hospital with a chief complaint of shortness of breath associated with sore throat that has been worsening over the last 2 days.  Patient has noticed multiple wheezing nonproductive cough over the last couple days as well.  Patient was found to have COVID in the ER.  When seen, patient continues to have shortness of breath.  Otherwise patient has no fever, chills, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, difficulty with urination,   Clinical Summary Patient's work of breathing secondary to covid infection and asthma exacerbation improved with antibiotics, dexamethasone, and remdesivir.  Patient did no
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19 pneumonia, Cough, Dyspnoea
Clinical narrative: Patient is a 76 y.o. male PMHx severe dementia who presented from his  memory care unit  on 7/20/2023 with CC cough, dyspnea. Found to have acute hypoxic respiratory failure secondary to COVID-19 pneumonia with possible superimposed bacterial pneumonia. After GOC discussion we have transitioned to comfort focused care. Comfort care medications ordered.  Hospice was consulted. Per family request, the patient was transferred to another facility on 7/24 evening.
Age: 13.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Erythema, Peripheral swelling
Clinical narrative: PATIENT RIGHT ARM GOT RED AND SWOLLEN .
Age: 82.0
Sex: F
Vaccine: COVID19-2
Symptoms: Anticoagulant therapy, Asthenia, Atrial fibrillation, Blood creatinine normal, Blood fibrinogen increased
Clinical narrative: Patient is a 82 y.o. female patient of, MD with history of afib, HTN  presented to Hospital with  weakness, diarrhea, headache, cough, nasuea, body aches    Covid-19 Virus Infection Date of onset of symptoms: 7/21/23  Symptoms present on admission: cough weakness, diarrhea, nausea, cough, body aches  Date of covid positive test: 7/24/23  Afebrile, HR 119 max, RR 18-25, BP soft in ER as low as 95/57  Imaging: CXR lungs clear, NAD on admit  LA  2.2, D Dimer <.27, CBC normal, Creatinine 0.97, troponin 7 Oxygen requirements on admission: none Medical therapy: not a candidate Consultants following: none  Baseline fibrinogen 575, ferritin 36 , CRP 85 , LDH 199  Albuterol PRN Guaifenesin Continuous pulse ox PT/CM 07/25/23 At time of exam patient request discharge home. Inquiring about Paxlovid. E-consult to ID Mild dehydration  P/w diarrhea, poor intake, low BP IV fluids x 1 liter to avoid overload 07/25/23 SBP now 110.    Lactic acidosis  Initial 2.2 - repat 2.1  Suspect  dehydration rather then sepsis IV fluids   Afib HTN EKG: afib RVR rate 105 initially  Suspect fast rates from dehydration , improved to 75  Anticoagulated with coumadin Pharmacy consult to dose
Age: 82.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blood lactate dehydrogenase increased, Blood lactic acid, C-reactive protein increased, COVID-19, Chest X-ray normal
Clinical narrative: Patient is a 82 y.o. female patient of, MD with history of afib, HTN  presented to Hospital with  weakness, diarrhea, headache, cough, nasuea, body aches    Covid-19 Virus Infection Date of onset of symptoms: 7/21/23  Symptoms present on admission: cough weakness, diarrhea, nausea, cough, body aches  Date of covid positive test: 7/24/23  Afebrile, HR 119 max, RR 18-25, BP soft in ER as low as 95/57  Imaging: CXR lungs clear, NAD on admit  LA  2.2, D Dimer <.27, CBC normal, Creatinine 0.97, troponin 7 Oxygen requirements on admission: none Medical therapy: not a candidate Consultants following: none  Baseline fibrinogen 575, ferritin 36 , CRP 85 , LDH 199  Albuterol PRN Guaifenesin Continuous pulse ox PT/CM 07/25/23 At time of exam patient request discharge home. Inquiring about Paxlovid. E-consult to ID Mild dehydration  P/w diarrhea, poor intake, low BP IV fluids x 1 liter to avoid overload 07/25/23 SBP now 110.    Lactic acidosis  Initial 2.2 - repat 2.1  Suspect  dehydration rather then sepsis IV fluids   Afib HTN EKG: afib RVR rate 105 initially  Suspect fast rates from dehydration , improved to 75  Anticoagulated with coumadin Pharmacy consult to dose
Age: 82.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cough, Dehydration, Diarrhoea, Electrocardiogram abnormal, Fibrin D dimer
Clinical narrative: Patient is a 82 y.o. female patient of, MD with history of afib, HTN  presented to Hospital with  weakness, diarrhea, headache, cough, nasuea, body aches    Covid-19 Virus Infection Date of onset of symptoms: 7/21/23  Symptoms present on admission: cough weakness, diarrhea, nausea, cough, body aches  Date of covid positive test: 7/24/23  Afebrile, HR 119 max, RR 18-25, BP soft in ER as low as 95/57  Imaging: CXR lungs clear, NAD on admit  LA  2.2, D Dimer <.27, CBC normal, Creatinine 0.97, troponin 7 Oxygen requirements on admission: none Medical therapy: not a candidate Consultants following: none  Baseline fibrinogen 575, ferritin 36 , CRP 85 , LDH 199  Albuterol PRN Guaifenesin Continuous pulse ox PT/CM 07/25/23 At time of exam patient request discharge home. Inquiring about Paxlovid. E-consult to ID Mild dehydration  P/w diarrhea, poor intake, low BP IV fluids x 1 liter to avoid overload 07/25/23 SBP now 110.    Lactic acidosis  Initial 2.2 - repat 2.1  Suspect  dehydration rather then sepsis IV fluids   Afib HTN EKG: afib RVR rate 105 initially  Suspect fast rates from dehydration , improved to 75  Anticoagulated with coumadin Pharmacy consult to dose
Age: 82.0
Sex: F
Vaccine: COVID19-2
Symptoms: Full blood count normal, Headache, Heart rate increased, Hypophagia, Hypotension
Clinical narrative: Patient is a 82 y.o. female patient of, MD with history of afib, HTN  presented to Hospital with  weakness, diarrhea, headache, cough, nasuea, body aches    Covid-19 Virus Infection Date of onset of symptoms: 7/21/23  Symptoms present on admission: cough weakness, diarrhea, nausea, cough, body aches  Date of covid positive test: 7/24/23  Afebrile, HR 119 max, RR 18-25, BP soft in ER as low as 95/57  Imaging: CXR lungs clear, NAD on admit  LA  2.2, D Dimer <.27, CBC normal, Creatinine 0.97, troponin 7 Oxygen requirements on admission: none Medical therapy: not a candidate Consultants following: none  Baseline fibrinogen 575, ferritin 36 , CRP 85 , LDH 199  Albuterol PRN Guaifenesin Continuous pulse ox PT/CM 07/25/23 At time of exam patient request discharge home. Inquiring about Paxlovid. E-consult to ID Mild dehydration  P/w diarrhea, poor intake, low BP IV fluids x 1 liter to avoid overload 07/25/23 SBP now 110.    Lactic acidosis  Initial 2.2 - repat 2.1  Suspect  dehydration rather then sepsis IV fluids   Afib HTN EKG: afib RVR rate 105 initially  Suspect fast rates from dehydration , improved to 75  Anticoagulated with coumadin Pharmacy consult to dose
Age: 82.0
Sex: F
Vaccine: COVID19-2
Symptoms: Lactic acidosis, Nausea, Pain, SARS-CoV-2 test positive, Serum ferritin normal
Clinical narrative: Patient is a 82 y.o. female patient of, MD with history of afib, HTN  presented to Hospital with  weakness, diarrhea, headache, cough, nasuea, body aches    Covid-19 Virus Infection Date of onset of symptoms: 7/21/23  Symptoms present on admission: cough weakness, diarrhea, nausea, cough, body aches  Date of covid positive test: 7/24/23  Afebrile, HR 119 max, RR 18-25, BP soft in ER as low as 95/57  Imaging: CXR lungs clear, NAD on admit  LA  2.2, D Dimer <.27, CBC normal, Creatinine 0.97, troponin 7 Oxygen requirements on admission: none Medical therapy: not a candidate Consultants following: none  Baseline fibrinogen 575, ferritin 36 , CRP 85 , LDH 199  Albuterol PRN Guaifenesin Continuous pulse ox PT/CM 07/25/23 At time of exam patient request discharge home. Inquiring about Paxlovid. E-consult to ID Mild dehydration  P/w diarrhea, poor intake, low BP IV fluids x 1 liter to avoid overload 07/25/23 SBP now 110.    Lactic acidosis  Initial 2.2 - repat 2.1  Suspect  dehydration rather then sepsis IV fluids   Afib HTN EKG: afib RVR rate 105 initially  Suspect fast rates from dehydration , improved to 75  Anticoagulated with coumadin Pharmacy consult to dose
Age: 82.0
Sex: F
Vaccine: COVID19-2
Symptoms: Troponin increased
Clinical narrative: Patient is a 82 y.o. female patient of, MD with history of afib, HTN  presented to Hospital with  weakness, diarrhea, headache, cough, nasuea, body aches    Covid-19 Virus Infection Date of onset of symptoms: 7/21/23  Symptoms present on admission: cough weakness, diarrhea, nausea, cough, body aches  Date of covid positive test: 7/24/23  Afebrile, HR 119 max, RR 18-25, BP soft in ER as low as 95/57  Imaging: CXR lungs clear, NAD on admit  LA  2.2, D Dimer <.27, CBC normal, Creatinine 0.97, troponin 7 Oxygen requirements on admission: none Medical therapy: not a candidate Consultants following: none  Baseline fibrinogen 575, ferritin 36 , CRP 85 , LDH 199  Albuterol PRN Guaifenesin Continuous pulse ox PT/CM 07/25/23 At time of exam patient request discharge home. Inquiring about Paxlovid. E-consult to ID Mild dehydration  P/w diarrhea, poor intake, low BP IV fluids x 1 liter to avoid overload 07/25/23 SBP now 110.    Lactic acidosis  Initial 2.2 - repat 2.1  Suspect  dehydration rather then sepsis IV fluids   Afib HTN EKG: afib RVR rate 105 initially  Suspect fast rates from dehydration , improved to 75  Anticoagulated with coumadin Pharmacy consult to dose
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Rash, Urticaria
Clinical narrative: Rash/Hives
Age: 86.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, COVID-19, Chronic obstructive pulmonary disease, Computerised tomogram liver abnormal, Computerised tomogram normal
Clinical narrative: Patient is a 86 y.o. female patient of, MD with history of CAD, hypertension, hyperlipidemia, former smoker, breast cancer presented to Hospital from nursing facility with hypoxia and confusion.   Acute metabolic encephalopathy resolved Etiology not clear, CT is negative Urine analysis was normal, per family history of frequent UTIs As per daughter mental status back to baseline    Acute respiratory failure with hypoxia Probable COPD 2/2 COVID-19 infection? Has about a 30-pack-year history of smoking but quit about 30 years ago per patient and daughter.   CT PE study negative for acute abnormality Auscultation revealed clear lung sounds, without wheezes.  No indication for Auscultation revealed clear lung sounds, without wheezes.  No indication for albuterol at this time.  Patient denies shortness of breath.  Has slight cough. Required 2 L but able to wean off to room air, encourage incentive spirometer   Covid-19 Virus Infection Date of onset of symptoms: Unsure Symptoms present on admission: Confusion Date of covid positive test: 7/13/2023 Vaccination status: Unknown Imaging: CT without evidence of PE or pneumonia  Oxygen requirements on admission: 2L Current oxygen requirements: On room air Medical therapy: steroids, cont on decadron for 6 more days at dc Consultants following: N/A Anticipated special isolation end date: 7/23/2023 Rectal bleeding with pain History of internal and external hemorrhoids, on rectal exam noted to have multiple external hemorrhoids with pain Frank BRBPR noted, started on sitz bath with Anusol HC Surgery consulted, recd rectal MRI given abnormal finding on rectal exam Daughter was unsure if they want to proceed with rectal MRI.  Continue maximum medical treatment and follow-up with surgery in 2 weeks as an outpatient for possible anoscopy and then discuss with family whether or not to pursue additional testing    Coronary artery disease No history of chest pain EKG nonacute, troponin 19, recheck is pending Continue cardioprotective medications   Abnormal liver imaging H/o breast ca CT showed right hepatic lobe ill-defined low-density heterogeneous lesion With history of breast cancer malignancy is on differential Discussed with son-in-low, family not considering aggressive measures Possible liver mets Outpatient MRI if family will reconsider    Vascular dementia Continue ASA/statin    Essential hypertension Continue home medications As needed hydralazine for limited BPs above 170 systolic   RLE edema Chronic.  Right lower extremity venous Doppler-interval resolution of common femoral vein and right great saphenous vein noted  Daughter notes that patient might not be able to take blood thinners if needed though since she has had bleeding complications in the past.    History of breast cancer Continue on Femara
Age: 86.0
Sex: F
Vaccine: COVID19-2
Symptoms: Computerised tomogram thorax normal, Condition aggravated, Confusional state, Cough, Electrocardiogram normal
Clinical narrative: Patient is a 86 y.o. female patient of, MD with history of CAD, hypertension, hyperlipidemia, former smoker, breast cancer presented to Hospital from nursing facility with hypoxia and confusion.   Acute metabolic encephalopathy resolved Etiology not clear, CT is negative Urine analysis was normal, per family history of frequent UTIs As per daughter mental status back to baseline    Acute respiratory failure with hypoxia Probable COPD 2/2 COVID-19 infection? Has about a 30-pack-year history of smoking but quit about 30 years ago per patient and daughter.   CT PE study negative for acute abnormality Auscultation revealed clear lung sounds, without wheezes.  No indication for Auscultation revealed clear lung sounds, without wheezes.  No indication for albuterol at this time.  Patient denies shortness of breath.  Has slight cough. Required 2 L but able to wean off to room air, encourage incentive spirometer   Covid-19 Virus Infection Date of onset of symptoms: Unsure Symptoms present on admission: Confusion Date of covid positive test: 7/13/2023 Vaccination status: Unknown Imaging: CT without evidence of PE or pneumonia  Oxygen requirements on admission: 2L Current oxygen requirements: On room air Medical therapy: steroids, cont on decadron for 6 more days at dc Consultants following: N/A Anticipated special isolation end date: 7/23/2023 Rectal bleeding with pain History of internal and external hemorrhoids, on rectal exam noted to have multiple external hemorrhoids with pain Frank BRBPR noted, started on sitz bath with Anusol HC Surgery consulted, recd rectal MRI given abnormal finding on rectal exam Daughter was unsure if they want to proceed with rectal MRI.  Continue maximum medical treatment and follow-up with surgery in 2 weeks as an outpatient for possible anoscopy and then discuss with family whether or not to pursue additional testing    Coronary artery disease No history of chest pain EKG nonacute, troponin 19, recheck is pending Continue cardioprotective medications   Abnormal liver imaging H/o breast ca CT showed right hepatic lobe ill-defined low-density heterogeneous lesion With history of breast cancer malignancy is on differential Discussed with son-in-low, family not considering aggressive measures Possible liver mets Outpatient MRI if family will reconsider    Vascular dementia Continue ASA/statin    Essential hypertension Continue home medications As needed hydralazine for limited BPs above 170 systolic   RLE edema Chronic.  Right lower extremity venous Doppler-interval resolution of common femoral vein and right great saphenous vein noted  Daughter notes that patient might not be able to take blood thinners if needed though since she has had bleeding complications in the past.    History of breast cancer Continue on Femara
Age: 86.0
Sex: F
Vaccine: COVID19-2
Symptoms: Haemorrhoids, Hepatic lesion, Hypoxia, Imaging procedure abnormal, Mental status changes
Clinical narrative: Patient is a 86 y.o. female patient of, MD with history of CAD, hypertension, hyperlipidemia, former smoker, breast cancer presented to Hospital from nursing facility with hypoxia and confusion.   Acute metabolic encephalopathy resolved Etiology not clear, CT is negative Urine analysis was normal, per family history of frequent UTIs As per daughter mental status back to baseline    Acute respiratory failure with hypoxia Probable COPD 2/2 COVID-19 infection? Has about a 30-pack-year history of smoking but quit about 30 years ago per patient and daughter.   CT PE study negative for acute abnormality Auscultation revealed clear lung sounds, without wheezes.  No indication for Auscultation revealed clear lung sounds, without wheezes.  No indication for albuterol at this time.  Patient denies shortness of breath.  Has slight cough. Required 2 L but able to wean off to room air, encourage incentive spirometer   Covid-19 Virus Infection Date of onset of symptoms: Unsure Symptoms present on admission: Confusion Date of covid positive test: 7/13/2023 Vaccination status: Unknown Imaging: CT without evidence of PE or pneumonia  Oxygen requirements on admission: 2L Current oxygen requirements: On room air Medical therapy: steroids, cont on decadron for 6 more days at dc Consultants following: N/A Anticipated special isolation end date: 7/23/2023 Rectal bleeding with pain History of internal and external hemorrhoids, on rectal exam noted to have multiple external hemorrhoids with pain Frank BRBPR noted, started on sitz bath with Anusol HC Surgery consulted, recd rectal MRI given abnormal finding on rectal exam Daughter was unsure if they want to proceed with rectal MRI.  Continue maximum medical treatment and follow-up with surgery in 2 weeks as an outpatient for possible anoscopy and then discuss with family whether or not to pursue additional testing    Coronary artery disease No history of chest pain EKG nonacute, troponin 19, recheck is pending Continue cardioprotective medications   Abnormal liver imaging H/o breast ca CT showed right hepatic lobe ill-defined low-density heterogeneous lesion With history of breast cancer malignancy is on differential Discussed with son-in-low, family not considering aggressive measures Possible liver mets Outpatient MRI if family will reconsider    Vascular dementia Continue ASA/statin    Essential hypertension Continue home medications As needed hydralazine for limited BPs above 170 systolic   RLE edema Chronic.  Right lower extremity venous Doppler-interval resolution of common femoral vein and right great saphenous vein noted  Daughter notes that patient might not be able to take blood thinners if needed though since she has had bleeding complications in the past.    History of breast cancer Continue on Femara
Age: 86.0
Sex: F
Vaccine: COVID19-2
Symptoms: Metabolic encephalopathy, Proctalgia, Rectal haemorrhage, SARS-CoV-2 test positive, Troponin increased
Clinical narrative: Patient is a 86 y.o. female patient of, MD with history of CAD, hypertension, hyperlipidemia, former smoker, breast cancer presented to Hospital from nursing facility with hypoxia and confusion.   Acute metabolic encephalopathy resolved Etiology not clear, CT is negative Urine analysis was normal, per family history of frequent UTIs As per daughter mental status back to baseline    Acute respiratory failure with hypoxia Probable COPD 2/2 COVID-19 infection? Has about a 30-pack-year history of smoking but quit about 30 years ago per patient and daughter.   CT PE study negative for acute abnormality Auscultation revealed clear lung sounds, without wheezes.  No indication for Auscultation revealed clear lung sounds, without wheezes.  No indication for albuterol at this time.  Patient denies shortness of breath.  Has slight cough. Required 2 L but able to wean off to room air, encourage incentive spirometer   Covid-19 Virus Infection Date of onset of symptoms: Unsure Symptoms present on admission: Confusion Date of covid positive test: 7/13/2023 Vaccination status: Unknown Imaging: CT without evidence of PE or pneumonia  Oxygen requirements on admission: 2L Current oxygen requirements: On room air Medical therapy: steroids, cont on decadron for 6 more days at dc Consultants following: N/A Anticipated special isolation end date: 7/23/2023 Rectal bleeding with pain History of internal and external hemorrhoids, on rectal exam noted to have multiple external hemorrhoids with pain Frank BRBPR noted, started on sitz bath with Anusol HC Surgery consulted, recd rectal MRI given abnormal finding on rectal exam Daughter was unsure if they want to proceed with rectal MRI.  Continue maximum medical treatment and follow-up with surgery in 2 weeks as an outpatient for possible anoscopy and then discuss with family whether or not to pursue additional testing    Coronary artery disease No history of chest pain EKG nonacute, troponin 19, recheck is pending Continue cardioprotective medications   Abnormal liver imaging H/o breast ca CT showed right hepatic lobe ill-defined low-density heterogeneous lesion With history of breast cancer malignancy is on differential Discussed with son-in-low, family not considering aggressive measures Possible liver mets Outpatient MRI if family will reconsider    Vascular dementia Continue ASA/statin    Essential hypertension Continue home medications As needed hydralazine for limited BPs above 170 systolic   RLE edema Chronic.  Right lower extremity venous Doppler-interval resolution of common femoral vein and right great saphenous vein noted  Daughter notes that patient might not be able to take blood thinners if needed though since she has had bleeding complications in the past.    History of breast cancer Continue on Femara
Age: 86.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ultrasound Doppler, Urine analysis normal
Clinical narrative: Patient is a 86 y.o. female patient of, MD with history of CAD, hypertension, hyperlipidemia, former smoker, breast cancer presented to Hospital from nursing facility with hypoxia and confusion.   Acute metabolic encephalopathy resolved Etiology not clear, CT is negative Urine analysis was normal, per family history of frequent UTIs As per daughter mental status back to baseline    Acute respiratory failure with hypoxia Probable COPD 2/2 COVID-19 infection? Has about a 30-pack-year history of smoking but quit about 30 years ago per patient and daughter.   CT PE study negative for acute abnormality Auscultation revealed clear lung sounds, without wheezes.  No indication for Auscultation revealed clear lung sounds, without wheezes.  No indication for albuterol at this time.  Patient denies shortness of breath.  Has slight cough. Required 2 L but able to wean off to room air, encourage incentive spirometer   Covid-19 Virus Infection Date of onset of symptoms: Unsure Symptoms present on admission: Confusion Date of covid positive test: 7/13/2023 Vaccination status: Unknown Imaging: CT without evidence of PE or pneumonia  Oxygen requirements on admission: 2L Current oxygen requirements: On room air Medical therapy: steroids, cont on decadron for 6 more days at dc Consultants following: N/A Anticipated special isolation end date: 7/23/2023 Rectal bleeding with pain History of internal and external hemorrhoids, on rectal exam noted to have multiple external hemorrhoids with pain Frank BRBPR noted, started on sitz bath with Anusol HC Surgery consulted, recd rectal MRI given abnormal finding on rectal exam Daughter was unsure if they want to proceed with rectal MRI.  Continue maximum medical treatment and follow-up with surgery in 2 weeks as an outpatient for possible anoscopy and then discuss with family whether or not to pursue additional testing    Coronary artery disease No history of chest pain EKG nonacute, troponin 19, recheck is pending Continue cardioprotective medications   Abnormal liver imaging H/o breast ca CT showed right hepatic lobe ill-defined low-density heterogeneous lesion With history of breast cancer malignancy is on differential Discussed with son-in-low, family not considering aggressive measures Possible liver mets Outpatient MRI if family will reconsider    Vascular dementia Continue ASA/statin    Essential hypertension Continue home medications As needed hydralazine for limited BPs above 170 systolic   RLE edema Chronic.  Right lower extremity venous Doppler-interval resolution of common femoral vein and right great saphenous vein noted  Daughter notes that patient might not be able to take blood thinners if needed though since she has had bleeding complications in the past.    History of breast cancer Continue on Femara
Age: 79.0
Sex: M
Vaccine: FLU4, HEPA, PNC20, VARZOS
Symptoms: Chills, Pain in extremity
Clinical narrative: Patient complained about chills and arm pain.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: MONOVALENT VACCINE GIVEN WHEN BIVALENT SHOULD OF BEEN GIVEN PATIENT HAD NO SX
Age: 13.0
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: Patient received lower than authorized dose. Patient was 13 years at the time of administration, was supposed to receive adult formulation instead received pediatric formulation.
Age: 64.0
Sex: M
Vaccine: COVID19-2, HEPA, SMALLMNK
Symptoms: Dizziness
Clinical narrative: On Monday 08/07/2023 at approximately 9:25AM patient received COVID-19 Pfizer Bivalent (Lot# GM1767) on right deltoid IM, Havrix (Lot#772YT) on left deltoid IM and Jynneos (Lot#FDP00015) on left arm SQ. Patient was prescreened and denied allergies, medical conditions, or any contraindications to the vaccines. Patient reported he tolerated previous Covid-19 vaccination well. At approximately 9:45am patient reported dizziness while sitting down. Patient denied chest pain, shortness of breath and itchiness all over body. Patient reported he had not eaten breakfast and was also sitting in the direct path of the exhaust emissions of the neighboring RV.  Nurse offered water, juice, and granola bar to client. Patient accepted and tolerated well. Vital signs taken: BP: 145/70, HR 67, O2 97% by nurse. Patient continued to deny all symptoms of allergic reaction, SOB and chest pain. Patient reported that he had not eaten that day and had not taken his Blood Pressure medication for over a month. Patient reported a decrease in dizziness. PHN suggested that the client ambulate to his RV to get out of the path of the fumes. Patient stood and ambulated into his RV independently. Emergency Medical Services were offered in an abundance of caution by nurse. Patient refused. Patient confirmed that he was not alone, and that he had access to an operating cell phone. Nurse educated client on when to seek medical assistance.
Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: BIVALENT SHOULD HAVE BEEN ADMINISTERED
Age: 0.75
Sex: M
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: BIVALENT WAS SUPPOSED TO BE ADMINISTERED PATIENT HAD NO REACTIONS
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Chills, Headache, Nausea, Pain, Pyrexia
Clinical narrative: Within 30-60 minutes of injection the patient developed severe headache, body aches, chills, fever to 103F, nausea, vomiting.
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Vomiting
Clinical narrative: Within 30-60 minutes of injection the patient developed severe headache, body aches, chills, fever to 103F, nausea, vomiting.
Age: 0.5
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Wrong product administered
Clinical narrative: BIVALENT WAS SUPPOSED TO BE ADMINISTERED. PATIENT HAD NO REACTIONS
Age: 61.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Abdominal discomfort, Arthralgia, Back pain, Blister, Herpes zoster
Clinical narrative: Patient had shingles like blisters on her arm, neck and head, including just below the injection site of shingrix. She ran a fever, but was unaware of the exact temperature. She had an upset stomach. Patient also reported back, shoulder, and hip pain. She went to the ER and was told she had Shingles.
Age: 61.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Injection site vesicles, Pyrexia
Clinical narrative: Patient had shingles like blisters on her arm, neck and head, including just below the injection site of shingrix. She ran a fever, but was unaware of the exact temperature. She had an upset stomach. Patient also reported back, shoulder, and hip pain. She went to the ER and was told she had Shingles.
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023; No adverse event; Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired.), PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired.), PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired.) and PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023).    No concomitant medication was reported.  Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 35 out of 50 patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-735331:master case
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023; No adverse event; Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023) and PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023).    No concomitant medication was reported.  Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 29 out of 50 patients   This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-735331:Master case
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.; No adverse event; Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.) and PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.).    No concomitant medication was reported.   Suspect product dosage text was reported as unknown. The vial did not undergo any temperature excursions. Suspect vaccine expiry date was 11-May-2023.  It was reported that no adverse reactions have been reported by any patients.  No treatment medication was reported.  This case is reported for patient 30th out of 50 adult patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-735331:Master case, Patient 1 out of 50 (Lot AS7143C was administered on 5-JUN-2023)
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.; No adverse event; doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.).    No concomitant medication was reported.  Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 31 out of 50 patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-735331:Master case, Patient 1 out of 50 (Lot AS7143C was administered on 5-JUN-2023)
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023; No adverse event; Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired) and PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023).    No concomitant medication was reported.  Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 38 out of 50 patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-735331:master  case
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023; No adverse event; Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023) and PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023).    No concomitant medication was reported.  Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 39 out of 50 patients   This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-735331:Master case